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ABSTRACT

Lung diseases, cancers, and trauma can result in injury to the connective tissue
lining the lung, i.e., the pleura. Pleural injuries lead to pneumothoraxes or pleural
effusions, i.e., air or fluid leaking out of the lung respectively, and potential lung collapse
- an immediately life threatening condition. While several bioengineered soft tissue
sealants exist on the market, there is only one sealant FDA-approved for use in
pulmonary surgery. In addition, very limited techniques are presented in the literature for
characterizing the burst properties of hydrogel tissue sealants. For my thesis, I proposed
to develop a protocol for characterizing the burst properties of hydrogel sealants using a
novel burst pressure test chamber. I further proposed a novel combination of oxidation
and methacrylation reactions of alginate for tissue sealant applications, with a particular
focus on developing a pulmonary sealant. The proposed research objectives are: 1) To
develop protocol for testing hydrogel sealants for soft tissue applications; 2) To verify
alginate as a potential for tissue sealant applications; and 3) To optimize an alginate
hydrogel sealant and perform ex vivo analysis for a pleural sealant application. Alginate
materials with varying degrees of oxidation and methacrylation were synthesized and
characterized. Oscillatory rheometry was used to characterize material properties such as
viscosity, hydrogel gelation kinetics, and complex moduli. Burst pressure measurements
properties and failure mechanisms, i.e. delamination or material failure, were collected
for a liquid and dry-state application. Preliminary ex vivo mouse lung model testing
demonstrated that methacrylated alginate hydrogels are able to withstand physiological
pressures associated with breathing, and failure occurs within the hydrogel for adhesive
alginate-based tissue sealants.
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CHAPTER 1: MOTIVATION
1.1. Introduction
The lungs are a complex system of airways and alveoli, which permit for the gas
exchange vital to life. The average person breathes 12-20 breathes per minute, which
equates to roughly 21,000 cyclic loads per day or 550,000,000 cyclic loads over the life
of the lungs.1 During respiration, the diaphragm muscles helps expand the chest cavity,
causing a pressure difference in the cavity and allowing for air flow into and expansion of
the lungs.2 As with any system that sees repeated cyclic loading within a confined space,
minimized friction is critical for optimal function. This is accomplished in the chest
cavity via the visceral and parietal pleurae, which line the surfaces of the lung and chest
cavity respectively.2 These pleurae secrete small amounts of pleural fluid, which forms a
slippery coating between the thoracic cavity and the lungs, providing lubrication during
respiration.2 The pleura are also responsible for preventing fluids, such as air, lung
surfactant, mucus, etc., from leaking out of the lungs and into the pleural cavity
surrounding the lungs.3

Figure 1. Simplified schematic showing lungs and pleurae within the chest
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Each year, over one million people develop diseases which result in air
(pneumothorax) or liquid (pleural effusions) leaking out of the lung and into the pleural
space.4 These pleural diseases can be the result of a variety of diseases, such as
congestive heart failure, pneumonia, and lung cancer, or of physical trauma to the lung,
such as a puncture or tear.4 The resulting lung collapse can be immediately life
threatening and requires immediate intervention. A thoracentesis must be performed to
remove the trapped fluid and allow for the lung to expand.5 This is done by placing a
needle or tube in the pleural cavity to drain out the air or liquid. Depending on the cause
of the leak, chronic leaking, also known as a bronchopleural fistula, may occur and
repeated chest tube drainage may be necessary.6, 7
Several different methods have been developed to treat these chronic injuries in
the lung pleura. These methods include pleurodesis (chemical or physical),8-13 natural14-25
and synthetic polymer sealants.26-38 These treatments vary in physical characteristics and
mechanical properties, which alters efficacy, duration of treatment, and invasiveness as
pulmonary sealants.

Figure 2: Cartoon schematic of proposed study
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1.2. Goal of Study
Engineered tissue adhesives and surgical sealants are becoming more prevalent
in surgical suites as current medical and robotic technologies improve, simplifying the
procedures of complex internal surgeries. As these technologies advance, conventional
methods of sealing tissues, such as staples and sutures, become more cumbersome and
time-consuming.39 Currently there are very few effective treatments for persistent
pneumothoraxes and pleural effusions and only one FDA-approved pulmonary surgical
sealant to prevent recurring leaks as the underlying tissue is repaired. The overall goal of
this study is to investigate the potential use of alginate, an algae-derived biopolymer, as a
surgical sealant in pulmonary applications. Various chemical modifications will be
addressed for modifying the mechanical properties of alginate to serve as an artificial
pleura biomaterial. Alginate hydrogel solutions will be mechanically characterized
through oscillatory rheology. Protocols will be developed for characterizing the burst
properties of the resultant alginate hydrogels on a custom-fabricated burst pressure
device, modified from ASTM F2392-04R10, the standard test method for burst strength
of surgical sealants.40 Finally, ex vivo mouse model testing will be performed to test the
efficacy of the alginate material as a pulmonary sealant.

3

CHAPTER 2: Background and Literature Review
2.1. Pleurodesis
In the 1990’s pleurodesis thoracostomy was the current, and most commonly
practiced treatment for pneumothorax and pleural effusion to prevent further leakage into
the pleural cavity after the initial removal of fluid.11 “The aim of pleurodesis is to achieve
a symphysis between visceral and parietal pleural layers, in order to prevent
accumulation of either air or fluid in the pleural space”.

12

Physical pleurodesis is a

surgical technique involving suturing or pleural abrasion procedures through the use of
thoracotomy, which involves creating an incision into the pleural space and using
advanced video-assisted thoracic surgery (VATS). VATS enables a small video camera
to be put into the chest cavity, giving the surgeon more visibility during surgery and
allowing for a much safer procedure.13 Once inside the chest cavity, the hole can be
sutured shut via a staple or pleural abrasion can be done. Pleural abrasion involves
irritating the parietal pleura using a domestic nylon scouring pad or gauze. Due to this
inflammation, the visceral and parietal pleurae become adhered to each other, sealing the
leak site.9 Chan et al studied 88 video-assisted thoracoscopic pleurodesis surgeries from
1992 to 1998, where the parietal pleura was abraded with a piece of Marlex mesh scratch
pad.41 Of those 88 there were only five recurrences (5.7%).13 With most patients under
general anesthesia the pain levels remained fairly low, 64 cases reported a 0 pain level
(72.7%).13
Chemical pleurodesis consists of applying a chemical solution on the lung wall
via a chest tube to cultivate an inflammatory response, adhering the pleurae and
preventing leakage. Several different chemicals have been used to induce this
4

inflammation based on availability, cost, efficiency, effectiveness and safety.11 A
concentrated tetracycline solution, which causes an effective seal, was commonly used in
early trials of chemical pleurodesis.8

Parenteral tetracycline, however, is no longer

commercially available in the U.S. due to a shortage, which led to a search for a
substitute.10,

11

Currently doxycycline, bleomycin, and talc remain as reliable and

generally effective chemical agents and are of the most commonly used.

11

Doxycycline

was an immediate replacement for Tetracycline, but was quickly replaced since multiple
treatments were required for effectiveness, which is less than optimal.11 Bleomycin, an
antibiotic that binds DNA producing breakage and inhibits DNA synthesis, was shown to
be much more efficient, requiring less treatments than that of doxycycline.11 Bleomycin
is widely used because of its efficiency and sclerosing properties for pleurodesis,
however, some patients experience fatal alveolar injury due to the toxicity of the drug. 11
Zimmer et al. shows that bleomycin reduces pain and difficulty of breathing (dyspnea)
but the overall success rate of treatment still remains around 70%.11 Talc, a tri-layered
magnesium sheet silicate that is readily available, efficient, and cost effective, is more
commonly preferred in today’s treatments because of a high success rate.10 Talc is
applied either using a dry heat exposure as a poudrage (powder or dusting) or as a slurry
via thoracostomy. Both methods and compositions are effective in the control of
malignant pleural effusion.11 Not only does talc have high success rates, but the patient’s
difficulty breathing or dyspnea reduces the most compared with previous chemical
treatments. Although chemical pleurodesis has proven to have high success rates, the
procedure is intrusive and may have many negative short term effects, including fever,
pain, infection, and respiratory failure.10
5

2.2. Natural Polymeric Tissue Sealant Approaches
Hydrogels have been used in a widening variety of biomedical applications. Due
to their tunable mechanical properties through polymeric chemistry, much interest has
been shown in developing specialized hydrogel biomaterials for specific clinical use.
While the application of hydrogels as surgical sealants and wound treatment began
developing in the 1960’s, the use of hydrogels to treat pulmonary air leaks began in
earnest in the late 1980’s14. Early hydrogels used for pulmonary seals were composed of
naturally-derived polymers (collagen, fibrin), but many other naturally- and syntheticallyderived polymers have been investigated for surgical sealant applications as our
understanding of hydrogels increases.15, 16
Starting in the late 1990’s, fibrin began to be studied as a natural-based polymer
sealant. Fibrin sealant is a haemostatic and wound support product consisting of blood
coagulation factors fibrinogen, factor XIII, thrombin, aprotinin and calcium chloride.
This mixture gives rise to the formation of a stable, cross-linked fibrin clot. Granulation
tissue, new vascular tissue on the healing surface of a wound, can be seen 3 days after
implementation and proliferation of collagen fibers after 4-7 days.17 Studies have shown
that the clotting time is dependent on the concentration of thrombin in the sealant. For
thoracic and vascular surgical procedures it is common practice to perform suturing prior
to applying the fibrin solution. In a single-blind study, i.e. a study where the researcher
but not the subjects know the makeup of test and control groups, comparing suturing and
suturing with fibrin sealant, the length of stay in the hospital was one day less in patients
who received treatment for a variety of anastomoses with fibrin sealant than those who
6

did not. A reduction in the incidence of pulmonary (or bronchopleural) air leakage of
41% was associated with the use of fibrin sealant.17 In 2002, Fabian et al. discovered a
better application method for surgical applications using an aerosolized fibrin glue rather
than the topical application. In a randomized, single-blind study, Fabian et al. discovered
a 50% reduction of alveolar air leaks after pulmonary resection with the use of
aerosolized fibrin glue (HemaMyst® System) and standard stapling procedures compared
to just standard stapling procedures.18 The preparation of glue components only requires
roughly 5 minutes and another minute to apply the glue. Best of all it is relatively
inexpensive ranging from $70 and $90 per cc.18 The fibrin glue Tisseel®, is FDA
approved and is used in many applications.19 Despite this, fibrin glue has failed to
demonstrate efficacy for pulmonary applications in several small clinical trials.18
Another sealant that is being used is chitosan, which is derived from chitin.
Chitosan has many application is due to its biocompatibility, low toxicity, structure
similarity to glycosaminoglycan’s, and its ability to degrade with certain enzymes.16 Ono
et al. reported a bursting pressure of 51± 11 mmHg (69±15 cmH2O).20 This study
suggests that modified chitosan can form a more effective seal in aortic, tracheal, and
pulmonary applications, but is still being researched.
There are a few applications of multiple sealants being used. TachoComb®,
discovered by Matsutani et al., is a fibrin-glue coated collagen fleece that is able to
conform in shape to the pleural defect that it is applied to and withstand high pressures
(greater than 40 cmH2O). TachoComb® is combined with overlapping the defect with the
surrounding normal pleural tissue.21 An issue with TachoComb® is when applying the
material to a pleural defect it is difficult to keep it free of blood/fluid interaction
7

before implementing to the site. When the material comes in contact with blood it almost
instantly becomes very sticky and difficult to manipulate. Nakajima et al. discovered an
innovative design to deliver the TachoComb® via a rubber tube, then conveying it into
the application site and applying it using standard laparoscopic forceps.22 This allows the
TachoComb® to remain free of blood/fluid before it reaches its destination and allows
TachoComb® to be used in minimally invasive surgery. TachoComb® did not receive
FDA approval due to the use of bovine thrombin and aprotinin.
One concern with fibrin is how it can possibly transmit blood-borne diseases.
With this concern in mind, a new product has evolved called Integran. Integran is a sheet
type absorbable topical collagen hemostat which contains no blood-derived products. On
average Integran cut the number of air leaks by a third after application compared to
TachoComb® .23
Another natural polymer-based sealant involves the reaction of bovine serum
albumin (BSA) and glutaraldehyde, which covalently bond to form a flexible seal upon
mixing.24, 25 This reaction is used in the commercially available BioGlue®. The BSA and
glutaraldehyde solutions come in a dual syringe applicator, which mixes the solution as
they are applied. The FDA reported that BioGlue® grafts withheld pressures of 300
mmHg.26 This far exceeds the normal physiological pulmonary pressure associated with
respiration of 30 cmH2O.1, 3

2.3. Synthetic Polymeric Tissue Sealant Approaches
Due to its biocompatibility, low toxicity, and FDA approval, poly(ethylene
glycol) (PEG), also known as poly(ethylene oxide) (PEO) or poly(oxyethylene) (POE)
8

depending on the molecular weight, is the primary synthetic polymer used in repairing
pulmonary and alveolar air leaks, although there is interest in a surgical sealant based on
poly(lactic-co-glycolic acid) (PLGA).16, 27-31 One of the first PEG-based pulmonary seals
utilized a two-solution (primer-sealant) method with acrylate-capped poly(L-lactide) and
poly(trimethylene carbonate) and a photoinitator, Eosin-Y, to form a sealant.32-34 Upon
exposure of the photoinitiator to blue-green light, the primer and sealant polymerize to
form a crosslinked, flexible hydrogel network.33,

42

Macchiarini et al. reported a

polymerization time of 40 seconds.32 While this sealant is able to withstand pressures
exceeding peak pulmonary pressure, the application method requires intraoperative
photoinitation, which can be complicated.34 This PEG- based sealant is commercially
available in Europe and Canada as FocalSeal® and was approved by the FDA in 2000.
To avoid photoinitation, several two-solution, PEG-based surgical sealants were
developed which begin to polymerize after the two solutions are mixed.28, 35, 41 The earlier
of these sealants consisted of two basic components: PEG disuccinimidyl succinate
(PEG-SS2), a PEG derivative, and human serum albumin (HSA), a protein naturally
produced by the liver.28 The two solutions are mixed at the time of use and delivered
through a specialized dual-syringe system. Kobayashi et al. reported rapid chemical
crosslinking between the PEG-SS2 and HSA, forming a hydrogel within 15 seconds that
can withstand twice normal peak pulmonary pressure.28 A major drawback to this
hydrogel is that HSA is derived from blood plasma, which presents control and disease
problems. Commercially available Progel® utilizes this PEG-SS2 HSA chemistry. A
second PEG-based, two solution sealant consists of dilute PEG- hydrogen chloride and
PEG- sodium phosphate/sodium carbonate solutions, which come in a preassembled, dual
9

syringe applicator36. Campbell et al. reported a polymerization time of less than three
seconds after mixing, while Wallace et al. reported a burst strength five times greater than
peak pulmonary pressure.29,

36

This dual PEG-based-solution treatment is available in

Europe, but not the United States, commercially as CoSeal®. A third two-solution
surgical sealant utilizes PEG and trilysine, an essential amino acid, to form a hydrogel.
Similar to CoSeal® and Progel® , the PEG and trilysine solutions are mixed upon
application and crosslink within seconds to form a flexible hydrogel.35 Pederson et al.
reported a median bursting strength of 35 cmH2O, which is ablove normal PPP. This
technology was introduced as a surgical sealant in Europe as PleuraSeal®, but never
obtained FDA approval and later underwent a voluntary recall.
A final synthetic polymer sealant currently being tested as a surgical sealant
contrasts with the previously mentioned sealants due to a lack of liquid application,
greatly decreasing the difficulty of application.31 This patch sealant is composed of
PLGA-Poly(VP-AAc-AAc(NHS)) and adheres to the lung after application under
moderate pressure through rapidly formed amide bonds.37 Shea reported a bursting
strength of 140.6±58.2 cmH2O.38

2.4 Alginate
Alginate is a naturally-derived polysaccharide polymer composed of repeating
(1,4)-linked β-D-mannuronate (M) and α-L-guluronate (G) mers.43 (Figure 2Figure 3)
Alginate, derived from brown alga, is a popular polymer in the food, cosmetic, and
bioengineering fields due to its low-cost, abundant source, and biocompatible nature.16, 43,
44

As such, there are many commercially

available alginates with a wide range of
10

characteristics and mechanical properties for use in varying applications. Alginate is
popular among bioengineers due to its highly tunable physical properties and various
crosslinking methods.44-48 Composition, block length, and molecular weight are three
characteristics which, when altered, will drastically change the mechanical properties of
the resulting alginate hydrogel.43 Alginate derived from various brown algae will have
varying compositions of mannuronate and guluronate building blocks, which affects the
overall structure of the polymer. The repetition of these building blocks to form
consecutive G residues, consecutive M residues, and alternating M-G residues, and the
length of these residues, also greatly affects the properties of these polymers in different
applications.43 For example, guluronate blocks drive intermolecular cross-linking via
divalent cations. Increasing molecular weight changes the physical propertes of the
resulting gel, i.e. increased loading, stiffness, and moduli, while also increasing viscosity.
Longer chains are able to entangle and interact more readily than shorter chains, leading
to these increased properties. Addition of functional side groups and modifications to the
alginate backbone also provides an opportunity to tune properties for specific
applications.47, 48 These chemical modifications also allows alginate to be crosslinked in a
variety of manners. Typically alginate can be ionically crosslinked, however the addition
of functional side groups can allow for covalent, thermal, and improved physical
crosslinking. The research presented below is based on Manugel GMB alginate (FMC
Biopolymer), which has a high G block content and relatively high molecular weight (80120 kDa). Manugel GMB was chosen because the high G:M ratio allows for effective
ionic crosslinking via a calcium chloride reaction and the high molecular weight will
promote physical entanglement, which may allow for increased elasticity in the resultant
11

hydrogel.

Figure 3: Top- Chemical structure of alginate repeat units; Bottom- alginate chain
depicting short G-G, M-M, and M-G residues

2.4.1 Alginate Chemistry
Several groups have investigated chemical modification of alginate for a variety
of bioengineering applications.43, 45, 47 Jeon et al. reported methacrylating alginate via 1ethyl-3-(3-dimethylaminopropyl)-carbodiimide

hydrochloride

and

N-

hydroxysuccinimide, resulting in a photocrosslinkable alginate for therapeutic
materials.47 Skardal et al. reported a means of methacrylating hyaluronan, another
commonly used polysaccharide biopolymer, utilizing methacrylic anhydride in deionized
water.49 Lee et al. also explored other means of crosslinking alginate. This group was
able to covalently crosslink alginate with poly(ethylene glycol)-diamines.43
12

Besides

these means of covalently crosslinking alginate, there are several other means for alginate
gelation, such as thermal cross-linking, though these means fall outside the scope of this
study.43 Another chemical modification that has been explored in alginate chemistry is
oxidation. Several groups have used oxidation as a means of controlling the degradation
properties, i.e. rate of degradation, particle size, etc., of alginate.46, 48 Gomez et al. and
Jeon et al. both present slightly varying methods of oxidation via sodium periodate,
though many oxidizing agents exist. As this method seemed compatible with alginate,
sodium periodate oxidation was chosen as the desired method.

2.5 Mechanical Testing of Tissue Sealants and Adhesives
A literature review results in few cases of mechanical burst pressure testing of
soft hydrogel sealants. The American Society for Testing and Materials (ASTM) is the
best source of information on testing procedures for a wide range of materials. ASTM
F2392 Standard Test Method for Burst Strength of Surgical Sealants provided the basic
design for a burst pressure device.40 The protocol didn’t allow for testing of hydrogel
sealants with in situ photocrosslinking and was modified accordingly. Several other
standards provided information on collecting adhesive strength, but the load application
didn’t reflect pulmonary conditions and were not pursued.50-52
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CHAPTER 3: ALGINATE CHEMISTRY
3.1. Introduction
As was mentioned above, the mechanical and physical properties of alginate can
be changed via chemical modification. This can be done through the addition of
functional side groups or by modifying the backbone of the alginate itself. Care must be
taken when modifying any polymer, as the chemical modifications can have unintended
repercussions, such as chain scission. This study focuses on the addition of a functional
methacrylate side group and open-chain adduct conformation to tune properties for a
pulmonary sealant application.
3.2. Methacrylation Chemistry
In order to form an effective pulmonary hydrogel sealant, a safe and effective
means of crosslinking alginate into a hydrogel must first be addressed. Commercially
available sodium alginate can be crosslinked to form a hydrogel upon exposure to
calcium chloride, forming ionic bonds between the alginate chains. Unfortunately, the
resulting hydrogel is relatively weak, as the ionic bonds can be easily broken, and stiff,
not allowing the sealant to flex with the lung. Alternatively, the addition of functional
methacrylate side groups onto the alginate backbone allows for covalent bonding
between chains, forming a more durable hydrogel. Several methods have been developed
in order to methacrylate alginate to varying degrees. Control over the reaction is
paramount, as the degree of methacrylation will influence the final properties of the
hydrogel.

3.2.1. Aqueous Method

14

The first method investigated as a means of methacrylation was an aqueousbased reaction utilizing methacrylic anhydride (Sigma Aldrich). A 20-molar excess of
methacrylic anhydride is added to a 1% (w/v) sodium alginate solution.49 (Figure 4) The
resulting solution is treated with sodium hydroxide to maintain a solution pH of 8.5 and
allowed to stir for 12 hours. The solution is then further treated with sodium hydroxide to
a pH of 7.0 and dialyzed with deionized water for 3 days, adjusting the pH periodically.
The final solution is lyophilized and stored until testing and characterization. Since
methacrylic anhydride is poorly soluble in water, a 20-molar excess is required to ensure
the reaction occurs. This poor solubility and molar excess limits control over the
methacrylation reaction and therefore alginate methacrylated in this manner has a
theoretical modification of 100%, though full modification is seldom obtained. Sodium
alginate can be replaced with oxidized sodium alginate if oxidized methacrylated alginate
is desired. Proton nuclear magnetic resonance spectroscopy was utilized to determine the
degree of methacrylation, or ratio of methacrylate groups per repeat unit of alginate. This
was accomplished by calculating ratios of relative integrations of the methacrylate peaks
and alginate methyl proton.

Figure 4: Chemical synthesis of methacrylated sodium alginate via aqueous chemistry.
Methacrylation can occur at any of the hydroxide sites on any uronate ring.
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3.2.2. Anhydrous Method
The second method investigated for methacrylation was a novel reaction
utilizing anhydrous dimethyl sulfoxide (DMSO, Sigma Aldrich) and methacrylic
anhydride. Since methacrylic anhydride is more readily soluble in dimethyl sulfosxide, a
high molar excess is not required to ensure a proper methacrylation, allowing for more
control over the reaction. While sodium alginate is soluble in water, it is not readily
soluble in DMSO. In order to increase the solubility, an ion exchange is performed,
replacing the sodium ion with a dodecyltrimethylammonium ion. (Figure 5) This can be
accomplished by gradually mixing a 1% (w/v) alginate polymer solution in deionized
water with an equal volume of a 2-3% solution of dodecyltrimethylammonium bromide
(DTAB, Sigma Aldrich) in deionized water. Upon mixing, the sodium ion on the alginate
backbone reacts with the bromide ion in the DTAB, forming sodium bromide. The
remaining dodecyltrimethylammonium ions bind with the alginate backbone, forming a
compound that is insoluble in water, and falls out of the solution as a precipitate. The
supernatant (sodium bromide solution in deionized water) can be removed and the
remaining precipitate can be rinsed in deionized water several times and lyophilized. The
resulting dodecyltrimethylammonium alginate (Alg-DTA) polymer can be readily
solubilized in DMSO for the methacrylation reaction. For methacrylation, an Alg-DTA
solution in DMSO must be prepared under nitrogen gas flow to prevent any moisture in
the air from disrupting the reaction, with a final 1% (w/v) concentration of alginate. Next,
a 1:2 molar ratio of 4-dimethylaminopyridine (DMAP, Sigma Aldrich) to Alg-DTA is
added to the solution. The DMAP acts as a catalyst and allows for full modification with
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a lower molar excess.

For a theoretical 100% modification, a 4:1 molar ratio of

methacrylic anhydride to alginate is added under nitrogen flow and stirred overnight.
Altering the molar ratio of methacrylic anhydride to alginate allows for greater control
over the degree of methacrylation. After stirring, a molar equivalent of hydrochloric acid
is added to neutralize any remaining DMAP. This solution is dialyzed against deionized
water 1 day, followed by a 3 day dialysis against 0.8M sodium dibasic phosphate and a
further 3 day dialysis against deionized water. During the first dialysis, the resulting
methacrylated Alg-DTA polymer falls out of solution as the DMSO is replaced with the
less solubilizing deionized water. Dialyzing against 0.8M sodium dibasic phosphate
drives another ion exchance, replacing the dodecyltrimethylammonium ion with a sodium
ion. This enables the methacrylated alginate polymer’s solubility in water. The final
dialysis in deionized water removes any excess sodium ions from the polymer. The
polymer solution pH is periodically adjusted to 7.0. This final solution can be lyophilized
to a dry form. Sodium alginate can be replaced with oxidized sodium alginate if oxidized
methacrylated alginate is desired. Specifying the degree of methacrylation is desirable
because altering the degree of methacrylation changes the structure of the resulting
hydrogel network, directly impacting the mechanical properties of the hydrogel. For
example, a lower degree of methacrylation would result in a less crosslinked network that
may exhibit enhanced flexibility, allowing the hydrogel sealant to conform to the lung
surface during respiration. Materials with high and low degrees of methacrylation will be
prepared to see the effects on the resultant hydrogel. Proton nuclear magnetic resonance
spectroscopy was utilized to determine the degree of methacrylation, or ratio of
methacrylate groups per repeat unit of alginate. This was accomplished by calculating
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ratios of relative integrations of the methacrylate peaks and alginate methyl proton.

Figure 5: Chemical synthesis of methacrylated sodium alginate via Anhydrous chemistry.
Methacrylation can occur at any of the hydroxide sites on any uronate ring.

3.3. Oxidation Chemistry
Besides providing an effective sealing barrier, any pulmonary sealant must also
adhere to the lung surface and remain in place during respiration. Initial studies of
methacrylated alginate indicated an effective, if brief, sealing of puncture lung tissue
before patch delamination, i.e. separation from the lung surface without bursting.
Alginate inherently lacks cell adhesivity, explaining the cause of delamination and
presenting a new challenge to address. While there are many methods to promote cell and
tissue adhesion, one of the simplest methods is oxidation chemistry. Sodium periodate
(Sigma Aldrich) oxidation alters the conformation of the uronate residues to an openchain adduct (Figure 66), increasing the valence of the residue and allowing for improved
18

interaction with proteins, such as collagen, in the lung tissue.45,

48

For the oxidation

reaction, 1-2% (w/v) alginate and 2-5% (w/v) sodium periodate solutions are prepared in
deionized water in separate vessels. To achieve a theoretical full oxidation, a 1:1 mass
ratio of alginate to sodium periodate is used. Altering this ratio allows for control over the
degree of oxidation. The solutions are then mixed and allowed to stir for 24 hours at
room temperature in a dark environment. The resulting oxidized sodium alginate solution
is dialyzed against deionized water for 3 days and lyophilized to a dry form. Sodium
alginate can be replaced with methacrylated sodium alginate if oxidized methacrylated
alginate is desired. The oxidation reaction alters the structure of the uronate rings,
preventing methacrylation of the hydroxide group formerly at that site. Proton nuclear
magnetic resonance spectroscopy was utilized to determine the degree of methacrylation,
or ratio of methacrylate groups per repeat unit of alginate. This was accomplished by
calculating ratios of relative integrations alginate methyl proton and first methylene
proton.48

Figure 6: Chemical synthesis of oxidized sodium alginate via sodium periodate oxidation chemistry.
Oxidation reaction can alter the uronate ring for either guluronate or mannuronate.
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CHAPTER 4: RHEOLOGICAL CHARACTERIZATION
4.1. Introduction
After chemical modification, the first step to understanding the characteristics and
mechanical properties of the hydrogel precursors is through rheological testing. Rheology
is often used to characterize the deformation and loading characteristics of nonNewtonian fluids, such as polymer solutions. All measurements were carried out on a
rheometer (AR2000, TA Instruments) equipped with a Peltier cone-and-plate geometry
(40-mm diameter, 1°59′47″, hard anodized aluminum) maintained at 25°C

4.2. Viscosity and Shear Stress
Chemical modification of alginate may result in degradation, i.e. chain scission,
and reduction in the molecular weight of the alginate backbone, depending on the nature
of the chemical reaction. It has been documented that methacrylation chemistry can be
damaging to the alginate backbone and oxidation reactions have been used to partially
degrade polymers in various applications, thus changes in the polymer structure are
expected as a result of the modifications.43, 48 These structural changes result in materials
with varying mechanical properties, which were examined via rheology. Viscosity (Pa s)
and shear stress (Pa) of the polymer solutions were measured at varied shear rates, 1-100
(1/s), at 1% radial strain over one minute and analyzed using analytical software (TA
Data Analysis). The effect of shear rate on viscosity and shear stress values of 3% (w/v)
solutions is depicted below. (Figure 77) A 3% solution was chosen as it allows for
collection of reliable data while minimizing polymer use. Solution viscosities decreased
exponentially with increasing shear rates for all solutions tested. Compared to non20

modified alginate solutions, the aqueous methacrylated alginate (Alg-MA) solution
maintained relatively high viscosities and shear stresses. In contrast the methacrylated
and oxidized alginate (Alg-MA-Ox) solutions exhibited greatly reduced viscosities and
shear stresses when compared to alginate and Alg-MA solutions. This indicates the
oxidation reaction resulted in degradation, or chain scission, of the polymer backbone,
decreasing its stiffness, moduli, and viscosity. While both the 10 and 30 DOO Alg-MAOx were degraded, the 10 DOO sample had a slightly higher viscosity, indicating
increasing DOO increases degradation of the polymer backbone.

Figure 7: Rheological experiments were performed on 3% (w/v) Alg-MA and Alg-MA-Ox solutions
and (1:1) blends of Alg-MA and Alg-MA-Ox. (A) Viscosity vs. shear rate plots and (B) shear stress
vs. shear rate plots are shown, average values are reported. Aqueous methacrylation method.

To form an effective seal, a liquid tissue sealant must portray a viscosity suitable
to maintain a film over the defect during the curing process. While oxidation is required
to maintain adhesion to the pulmonary tissue, the necessary amount or degree of
oxidation has not been fully studied. Therefore, Alg-MA was blended with Alg-MA-Ox
to preserve the viscosity and material properties, while maintaining theoretical adhesion.
Alg-MA and Alg-MA-Ox blends (1:1) were

created
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from

the

same

aqueous

formulation of Alg-MA and Alg-Ox-MA with varying degrees of oxidation (10, 30, and
50%). (Figure 7) The viscosity and shear stress values for the blended solutions lie
between respective component values and were similar, indicating that the properties of
the Alg-MA polymer are dominant for viscosity and shear stress.

Figure 8: Rheological experiments were performed on 3% (w/v) Alg-MA, (1:1) blends of Alg-Ox-MA
and Alg-MA, and (1:1) blends of Alg-Ox and Alg-MA. Viscosity vs. shear rate average values are
reported. Anhydrous methacrylation utilized.

The effect of shear rate on viscosity for the latest generation of materials, those
oxidized and then methacrylated (Alg-Ox-MA) via the anhydrous method, are depicted
above. (Figure 88) Alginate was oxidized first to study an earlier hypothesis that
oxidation prior to methacrylation would result in a hydrogel with greater elasticity.
Alginate was oxidized to varying degrees (10, 30, or 50%) and subsequently
methacrylated to varying degrees (15 or 30%). Unfortunately, the 30 and 50 DOO
alginates proved too degraded for testing. This provided initial indication that oxidation
prior to methacrylation may result in a further degraded polymer. Unmodified alginate
was also methacrylated as a control. 3% (w/v) solutions of 15 DOM, 30 DOM, blended
(1:1) 10 DOO 15 DOM: 15 DOM, blended (1:1) 10 DOO 30 DOM: 30 DOM, blended
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(1:1) 10 DOO: 15 DOM, and blended (1:1) 10 DOO: 30 DOM were formed and fully
characterized. Solution viscosities decreased exponentially with increasing shear rates for
all solutions tested. Methacrylated alginates solution viscosity was relatively higher than
the blended solution viscosities, indicating polymer degradation due to the oxidation.
Solution viscosity also dropped due to the methacrylation reaction, evident by the
decreased viscosity for the 30 DOM solution compared to the 15 DOM material. Both
values were considerably lower than the solutions prepared via the aqueous method,
indicating the anhydrous reaction may be harmful to the polymer backbone.
4.3. Photocrosslinking and Gelation
Oscillatory time sweeps were conducted at 10% radial strain and 1 Hz during
exposure to green light (525 nm, custom 37/8 inch diameter LED ring, NFLS-G30X3WHT, SuperbrightLEDs) over a period of 10 minutes (600 seconds). Data collection was
initiated upon the start of light exposure. Shear storage (G′) and loss (G″) moduli were
recorded; tan delta (ratio of G″ to G′) was analyzed using analytical software (TA Data
Analysis). The gelation of Alg-MA and Alg-Ox-MA hydrogels was examined after shear
sweep experiments. Aqueous Alg-MA and Alg-Ox-MA solutions, in the presence of
photoinitiators, were crosslinked and formed into hydrogels upon exposure to green light.
Eosin Y in 1-vinyl-2-pyrrolidinone was used as photosensitizer and catalyst, while
triethanolamine served as an electron donor.53-57 The gelation times of the hydrogel
solutions were determined from oscillatory time sweep plots. (Figure 9 and Figure 10)
The initiation of gelation, i.e., gelation time, was determined to be at the inflection point
of the delta vs. time curve. The Alg-Ox-MA solutions with degrees of oxidation at or
above 30 failed to form a gel, i.e., photocrosslink, under rheological testing (data not
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shown). For the other Alg-MA and Alg-Ox-MA solutions and blends, there is a clear
inflection in the delta curve, indicative of successful photo-initiation and subsequent
crosslinking.
G′ is a better indicator for terminal crosslinking as it plateaus. (Figure 99 &
Figure 1010) Upon inspection of the G′ curves, it appears a majority or crosslinking has
been completed by 600 s. By this time, G′ has increased by several orders of magnitude
and the rate of change has decreased substantially. Thus, an exposure time of 10 minutes
(600 seconds) was used to form hydrogels for burst testing. These behaviors are evident
in the solutions prepared via the aqueous methacrylation chemistry. Materials with lower
degrees of methacrylation, i.e. those prepared via anhydrous methacrylation, did not fully
plateau, although G′ is still orders of magnitude higher, indicating elastic hydrogel
formation. Rheological values collected past the ten minute point can become unreliable
as the sample dehydrates. This dehydration would also cause G′ to increase, preventing a
plateau.
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Figure 9: Rheological experiments were performed on 3% (w/v) Alg-MA and Alg-MA-Ox solutions
and (1:1) blends of Alg-MA and Alg-MA-Ox. Top left depicts delta vs. time for Alg-MA, 10 DOO
Alg-MA-Ox, and 30 DOO Alg-MA-Ox. Top right depicts complex moduli vs. time for Alg-MA, and
10 DOO Alg-MA-Ox. Bottom left depicts delta vs. time for (1:1) blends of Alg-MA and Alg-MA-Ox.
Bottom right depicts complex moduli vs. time for (1:1) blends of Alg-MA and Alg-MA-Ox. Gelation
time indicated by black arrow. Aqueous methacrylation utilized.

Figure 10: Rheological experiments were performed on 3% (w/v) Alg-MA, (1:1) blends of Alg-OxMA and Alg-MA, and (1:1) blends of Alg-Ox and Alg-MA. Left depicts delta vs. time. Right depicts
complex moduli vs. time. Gelation time indicated by black arrow. Anhydrous methacrylation
utilized.
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CHAPTER 5: BURST PRESSURE TESTING
5.1. Introduction
Burst pressure values were determined following ASTM F2392-04R10, with
minor modifications for our photo-crosslinking hydrogel. Data was measured via a
custom built device designed according to the standard. The main pressure vessel was
machined from polyether ether ketone (PEEK) to provide low cost fabrication and
resistance to degradation regardless of the pressurizing fluid. The main vessel measures
2½ inches in diameter and 17/8 inches in height and is built in two pieces to allow for easy
specimen loading between the sections. The top section is fastened by means of two ¼”20 thread x 1½ inch length bolts permanently fixed in the lower section and held in place
by two stainless steel thumbscrews. The lower section has a 7/16 inch diameter hole to
allow fluid from a syringe pump to apply pressure to the substrate, while the top section
has a 7/8 inch diameter hole, allowing the substrate to react under loading. A 1 inch
diameter fluoroelastomer o-ring is placed between the sample and top section to provide
an airtight seal, ensuring that the fluid pressure is applied to the specimen. (Figure 111)
A syringe pump (Harvard Apparatus PHD 2000 Infusion) was used to pressurize
the system, which can be used in conjunction with a variety of physiologically relevant
fluids. A 60 cc, 26.7 mm diameter syringe (ExelInt) was fixed into the syringe pump and
connected to ¼ inch diameter plastic tubing via a male luer to tube hose adapter. The
tubing attaches to the pressure vessel via a NPT port bored into the body. A pressure
transducer (Omega PX-409-030AUSBH) also is connected to the pressure vessel through
a NPT port, allowing for accurate, real-time data acquisition via a connected computer.
(Figure 111) Failure mechanism (adhesive or material failure) was assessed via visual
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inspection of the specimen and a digital microscope (Dino-Lite Pro AM413TA, DinoLite Digital Microscopes) during and after testing.

Figure 11: Schematic illustration of testing setup for mechanical burst pressure testing of alginatebased sealants.

5.2. Liquid Sealant Testing
A burst pressure testing protocol was developed and performed utilizing a liquid
sealant application. All burst pressure tests were conducted at room temperature with
compressed air at an infusion rate of 75ml/hr. Collagen testing substrates (collagen
middles natural protein, The Sausage Maker Inc.) were rehydrated for five minutes in
deionized water. Prior to testing, the substrate is fixed into the burst pressure device and
pressurized to ensure an intact substrate and proper seal. The substrates were next
punctured with a 3mm diameter biopsy punch and retested to ensure a through-thickness
defect was formed. Punctured substrates were clamped between a glass slide and a Teflon
mold with a 15mm diameter hole centered on the collagen puncture. Hydrogel pre-cursor
solution (0.5mL) was deposited into the mold, forming a film over the puncture. The
mold is then placed on a reflective surface, such as aluminum foil, encircled with a
27

custom,

37/8in

diameter

LED

ring

(525nm,

NFLS-G30X3-WHT

LEDs,

SuperbrightLEDs), covered with a reflective material, and photocrosslinked for ten
minutes.
After crosslinking, the collagen substrates were unclamped and the Teflon mold
was carefully removed so as not to disturb the hydrogel sealant. The collagen substrates
are then removed carefully from the slide to ensure the sealant is not stressed. The
substrate is positioned in the burst pressure device such that the defect and hydrogel
sealant are centered in the device. The fluroelastomer o-ring is centered around the
sealant with no overlapping and top section of the device is clamped in place. The syringe
pump is enabled and the sealant is tested until failure. Close visual inspection and notes
of the testing were made in order to determine the mode of failure. Utilization of a digital
microscope and video recording software greatly enhanced the ability to precisely
characterize the mode of failure, as the sealant tends to fail in a sudden manner. Figure
122, below, depicts the modes of failure experienced while testing the liquid sealant.

Intact Sealant

Delamination

Material Failure

Figure 12: Cartoon schematic and images of failure modes.
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Results from burst pressure testing are shown in Figure 133, with a
physiologically relevant pulmonary pressure plotted for reference, and summarized in
Table 1. While the Alg-MA hydrogel withstood the greatest individual pressure, it also
had the highest standard deviation amongst the groups. In order to understand the burst
pressure results fully, the mode of failure must be accounted for. Two modes of failure,
delamination and material, were observed during testing. Delamination occurs when the
hydrogel patch separates from the substrate with no visible sign of damage. Material
failure, conversely, occurs when the area directly above the puncture fails, resulting in
damage to the patch. The Alg-MA patches failed exclusively through delamination, while
the Alg-MA-Ox patches experienced material failure, with the exception of a single 10
DOO Alg-MA-Ox:Alg-MA blend trail. Since alginate is inherently non-adhesive, the
wide variation in burst pressure in Alg-MA could be explained by the mode of failure.
The Alg-MA-Ox and blended materials are able to adhere to the substrate due to the
increased substrate interaction resulting from the open-adduct conformation and adhere

Figure 13: Burst pressure for successful liquid hydrogel sealant (aqueous reaction). Standard error
mean is depicted. The physiological line represents 30cmH2O, a widely used maximum threshold for
respiration before pulmonary damage can occur
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until material failure occurs. The only case of delamination outside the Alg-MA group
occurred in the blend with the lowest theoretical degree of oxidation. This lower
oxidation provides fewer interactions with the substrate, possibly enabling delamination.
Table 1: Summary of Liquid Sealant Burst Pressure Testing

Group

Degree of
Methacrylation
(%)

Degree of
Oxidation
(%)

Burst
Pressure
(in H2O)

Mode of
Failure

Alg-MA

77

n/a

26.42 ± 12.01

Delamination

Alg-MA-Ox

70

10

13.96 ± 7.02

Material

Alg-MA-Ox
Alg-MA Blend

73.52

5

25.69 ± 5.69

Delamination (1)
Material

Alg-MA-Ox
Alg-MA Blend

70.5

12.5

18.93 ± 5.70

Material

Alg-MA-Ox
Alg-MA Blend

54

19.8

14.79 ± 6.61

Material

5.3. Patch Sealant Testing
One of the greatest issues with the liquid sealant application is keeping the
hydrogel in place over the defect during gelation. This problem was overcome in earlier
testing by using a Teflon mold, but this solution would prove nearly impossible in lung
tissue applications. Therefore, a solid hydrogel patch was devised to overcome this issue.
The dry patch could be applied to the lung surface, hydrated with fluids present on the
tissue surface, and photocrosslinked in situ. 15 DOM, 30 DOM, blended (1:1) 10 DOO
15 DOM: 15 DOM, blended (1:1) 10 DOO 30 DOM: 30 DOM, blended (1:1) 10 DOO:
15 DOM, and blended (1:1) 10 DOO: 30

DOM
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solutions

were

mixed

with

photoinitiators to achieve viscous solutions. The resulting solutions were then spun onto
glass slides and lyophilized to form dry, thin films. The resulting films were removed
from the slide, punched into 8mm diameter patches, and stored until testing. Once the
photoinitiator is introduced to the system, all fabrication and handling of the material
must occur in a dark environment and under red light to prevent gelation from occurring
prior to application.
A new protocol was developed to characterize the burst properties of the
resulting patches. Burst pressure testing was performed in an environmental incubator
maintained at 37° C with compressed air at an infusion rate of 75ml/hr. Collagen
substrates (collagen middles natural protein, The Sausage Maker Inc.) were rehydrated
for five minutes in deionized water. Prior to testing, the substrate is fixed into the burst
pressure device and pressurized to ensure an intact substrate and proper seal. The
substrate was next punctured with a 1.5mm diameter biopsy punch and inspected to
ensure a through-thickness defect was formed. The substrate surface is placed on a glass
slide and wetted to allow the patch to begin hydrating upon application. Since the patches
were thinner than expected, two 8mm diameter patches are placed above the defect and
wetted with deionized water from an eyedropper. Enough water was applied for the
patches to become fully hydrated without becoming supersaturated, which could lead to
disintegration of the patches. The substrate is then covered with the Teflon mold to
prevent dehydration as a result of close proximity to LEDs during gelation. The glass
slide is placed on a reflective surface, such as aluminum foil, encircled with a custom,
37/8in diameter LED ring (525nm, NFLS-G30X3-WHT LEDs, SuperbrightLEDs),
covered with a reflective material, and

photocrosslinked for ten minutes.
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After crosslinking, the collagen substrates are removed evenly from the slide to
ensure the sealant is not stressed. The substrate is positioned in the burst pressure device
such that the defect and hydrogel sealant are centered in the device. The fluroelastomer oring is centered around the sealant with no overlapping and top section of the device is
clamped in place. The syringe pump is enabled and the sealant is tested until failure. A
digital microscope and video recording software is used to precisely characterize the
mode of failure, as the sealant tends to fail in a sudden manner.
Results from burst pressure tests for the solid application are depicted in Figure
144 and summarized in Table 2. Both Alg-MA groups saw relatively high burst
pressures, but also have high deviations. The only blended material with significant burst
pressures is the 10 DOO:30 DOM blended material. Alg-Ox-MA: Alg-MA (1:1) blends
experienced very low burst pressures compared to the Alg-MA groups, which suggests
the material was highly degraded. Oxidation is known to degrade polymer chains and
alters the conformation of the alginate uronate residue such that the functional
methacrylate side group is unable to bind. This potentially limited the efficiency of the
methacrylation reaction and resulted in alginates with lower degrees of methacrylation
than expected. This lower degree of methacrylation would result in a less crosslinked
polymer network and ultimately result in a weaker sealant. As was the case with the
liquid application, methacrylated alginates failed exclusively through delamination, while
the groups blended with oxidized alginate experienced exclusively material failure before
delamination could occur. This data also suggests that a simple blend of oxidized and
methacrylated alginate shows potential as a surgical sealant. Further study of these blends
will need to be performed to determine the extent of polymer interaction between the two
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materials and whether separation could occur in time. Since the methacrylation method,
degree of methacrylation, and order of oxidation and methacrylation all changed between
the generations of hydrogel sealants, it is not possible to declare either the liquid or drystate application method superior at this time.

Figure 14: Burst pressure for solid hydrogel patch sealant. Standard error mean is depicted. Left
depicted groups with 15 DOM materials. Right depicts groups with 30 DOM materials.

Table 2: Summary of Solid Patch Sealant Testing

Group

Theoretical
DOM
(%)

Theoretical
DOO
(%)

Burst
Pressure
(in H2O)

Mode of
Failure

Alg-MA

15

n/a

51.94 ± 22.94

Delamination

Alg-MA

30

n/a

52.12 ± 7.42

Delamination

Alg-Ox-MA
Alg-MA Blend

15

5

2.56 ± 0.56

Material

Alg-Ox-MA
Alg-MA Blend

30

5

7.81 ± 5.90

Material

Alg-Ox Alg-Ma
Blend

7.5

5

1.98 ± 0.79

Material

Alg-Ox Alg Ma
Blend

15

5

46.83 ± 11.46

Material
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CHAPTER 6: EX VIVO LUNG TESTING
6.1. Introduction
Initial mechanical performance of the hydrogel sealants were studied via ex vivo
mouse lung models. The amount of time and resources going into these ex vivo studies,
however, was not sustainable for high throughput studies or for developing an optimized
material. Therefore we transitioned away from the mouse lung model for early iterations
of materials, instead developing an in-laboratory characterization that allowed for rapid
testing. While testing on the burst pressure device provides a quick and easy way to
gather the burst pressure of a hydrogel sealant, the testing conditions do not match
physiological pulmonary conditions. In order to prove an effective pulmonary sealant, ex
vivo mouse lung testing must be performed to more closely simulate physiological
application. Lungs are promptly excised from euthanized mice and cannulated. Once
excised, the lungs are placed in phosphate buffer solution and mechanically tested on a
ventilator. Unfortunately, later iterations of the alginate hydrogel sealant were not
assessed via the mouse lung model.
6.2 Excision
In order to perform successful ex vivo testing, an intact lung must first be
excised. Mice are euthanized using by lethal administration of sodium pentobarbital
according to accepted AAALAC and institutional standards and under existing IACUC
protocol (CHRMS 15-008). The mouse is then stretched and pinned onto a rubber
surgical mat. An incision is made in the neck and the skin is pulled to the side, exposing
the neck muscles. These muscles are carefully cut to expose the trachea. An incision is
made in the trachea so that a cannula can be inserted and tied in place via suture thread.
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An incision is then made below the ribs and connected to the neck. The skin covering the
chest can then be pulled to the side, exposing the abdomen and rib cage. Cutting through
the abdomen and pulling back the liver will expose the diaphragm, which can be
punctured to deflate the lungs. Next, the ribs and connective tissue lining the lungs is
removed with care to ensure that the lungs remain intact. After the connective tissue is
removed, the lungs can be removed from the chest cavity and placed in phosphate buffer
solution for testing.
6.3 Mechanical Testing
Once excised, the lungs can then be tested on either a Minivent or Flexivent
ventilator. The Minivent gives the user to ventilate the lungs with control over the tidal
volume and stroke rate. Lungs are connected to the Minivent via the cannula and
ventilated to ensure the lung was properly excised with no puncture. Successfully excised
lungs are then punctured and re-ventilated to confirm a leak as a result of the defect.
Excised lungs are then sealed with the alginate hydrogel sealant and allowed to crosslink.
Finally, the lungs are ventilated at 2 cm positive end-expiratory pressure over a range of
tidal volumes until the sealant fails. The maximum sealant conditions are recorded and
the tissue and sealant are observed to determine mode of failure. The Flexivent give the
user the ability to perform more complicated ventilation techniques via a computer
program. Sensors are also used to measure the volume and pressure during ventilation.
Lungs tested on the Flexivent are subjected to similar initial testing to validate an
uninjured lung and subsequently confirm the puncture leak. The results from early ex vivo
testing on the MiniVent and FlexiVent are summarized below in Table 3 and Table 4,
respectively.
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Table 3. Summary of Initial MiniVent Testing

Material
Alg-MA
Alg-MA
Alg-MA
Alg-MA

Application Stroke Rate Tidal Volume at Failure
Mode
(strokes/min)
(μL)
Dry-State
180
325
Dry-State
180
250
Dry-State
180
350
Liquid
180
330

Failure Mode
Delamination
Delamination
Delamination
Delamination

Table 4. Summary of Initial FlexiVent Testing

Material

Application
Mode

Pressure at Failure
(cmH2O)

Failure Mode

Alg-MA
Alg-MA
Alg-MA

Dry-State
Dry-State
Liquid

25
30
25

Delamination
Delamination
Delamination

Initial testing on ex vivo mouse lungs indicated that alginate-based hydrogels
were able to mechanically withstand physiologically relevant conditions before
delaminating. The repetitive delamination failures showed the need for improved
adherence to the tissue substrate, which alginate inherently lacks. While both MiniVent
and FlexiVent testing suggests the alginate hydrogels can serve as pulmonary sealants, all
sealants delaminated shortly after loading. All methacrylated alginate tested via MiniVent
and Flexivent ventilation were synthesized via the aqueous methacrylation method.
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CHAPTER 7: CONCLUSIONS
7.1 Summary of Work
Each year thousands of individuals suffer from pleural defects or lung damage
as a result of trauma, cancer, or various other pulmonary diseases, resulting in fluid flow
into the pleural cavity. While short term solutions, such as thoracentesis or chest tube
drainage, are effective at draining the fluid from the pleural cavity, current treatment
methods for the long-term prevention of recurring leaks is still lacking. Several treatment
options do exist, but these treatments involve the chemical or physical irritation of the
pleural lining to inflame the tissue and adhere the two pleurae or synthetic polymer
sealants in conjunction with conventional methods, such as sutures or staples. Alginate, a
natural biopolymer derived from brown algae, was investigated as a potential alternative
tissue sealant for pulmonary surgical applications. Additionally, in-laboratory protocol
was developed for mechanical characterization of material burst pressure and failure
analysis.
Alginate

hydrogels

were

synthesized

using

high

molecular

weight,

commercially available Manugel GMB alginate. The alginate was chemically modified
via the addition of functional methacrylate side groups onto the polysaccharide backbone,
i.e. methacrylation, and the exposing of functional aldehyde groups through alteration of
the alginate uronate structure, i.e. oxidation. Methacrylation of alginate allows for
covalent crosslinking, which is preferred over the weaker divalent cation ionic
crosslinking of unmodified alginate. Though unmodified alginate inherently lacks celladhesivity, oxidation enables adhesion through the interaction of the exposed aldehyde
group and tissue proteins, such as collagen. Several synthesis methods were utilized,
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including aqueous and anhydrous methacrylation and sodium periodate oxidation. The
reaction order was also altered to investigate the hypothesis that oxidation prior to
methacrylation would result in a more elastic hydrogel. The oxidation reaction, and to a
lesser extent the anhydrous methacrylation reaction, results in high degrees of polymer
degradation via chain scission, limiting the application of oxidized methacrylated alginate
in its purest form. Therefore (1:1) blends of methacrylated alginate and oxidized
methacrylated alginate or oxidized alginate were studied as well.
Rheological testing of the hydrogel precursor solutions indicate that lower
degrees of oxidation result in less polymer degradation, with an upper limit of 10%
oxidized alginate indicated from testing. Oxidation before methacrylation degrades the
polymer, which is then more susceptible to further degradation during the methacrylation
reaction. Also, oxidation alters the alginate uronate rings, preventing methacrylation from
occurring as efficiently by eliminating potential binding sites for the methacrylate
functional group. While the initial hypothesis was that oxidation prior to methacrylation
might increase elasticity in the hydrogel network, the resulting degradation was too great.
Methacrylation prior to oxidation will achieve higher degrees of methacrylation and
lower degrees of degradation prior to oxidation. Low degrees of oxidation will also
prevent high degrees of degradation while also allowing improved tissue adhesion.
A burst pressure device was designed, fabricated, and implemented for
mechanical analysis of various alginate hydrogels and blended solutions. Protocol was
developed to test both a liquid and solid patch application method, allowing a wider
range of materials to be analyzed in laboratory. Several hydrogel solutions achieved burst
pressures of or exceeding relevant physiological pressures and exhibited bulk material
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failure opposed to not adhesive failure. These results are promising for further analysis of
visible-light crosslinked alginate-based sealants for pulmonary tissue repair.
7.2. Future Directions
Despite the promise of alginate hydrogels as surgical sealants for pulmonary
applications, continuing research is needed to develop a sealant for clinical use. Degree
of methacrylation and oxidation need to be fine-tuned to determine optimized chemical
modification of alginate for enhanced mechanical sealant properties while obtaining
effective tissue adhesion. An upper degree of oxidation has been defined in this study,
therefore lower degrees of oxidation should be investigated for improved adhesion with
minimal degradation. It is still unclear if lower degrees of methacrylation is superior to
higher degrees for a surgical sealant application. Hydrogels with higher degrees of
methacrylation or more densely crosslinked, leading to higher mechanical moduli, but
also increased stiffness. A successful surgical sealant must balance mechanical strength,
elasticity, and adhesion. Further investigation into the methacrylation reaction will allow
for a balance between mechanical strength and elasticity. Lastly, while this research
focused around the development of an in-laboratory means of mechanically
characterizing the burst strength and failure mode of hydrogels, ex vivo mouse lung
model testing must be performed on promising alginate hydrogel systems. In-laboratory
characterization allows for high throughput, rapid testing of hydrogels to determine
potentially successful systems, however this characterization method doesn’t simulate the
complex physiological environment in the pulmonary system. Ex vivo testing more
closely simulates physiological conditions and will allow for the selection of a final
alginate-based pulmonary surgical sealant.
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APPENDIX A: Standard Operating Procedures
A.1 Alginate Partial Oxidation
Goal: To perform partial oxidation chemical modification of the alginate polysaccharide
polymer.
Materials:
 Alginate (FMC BioPolymer)
 Sodium Periodate, NaIO4 (Sigma Aldrich)
 Deionised water
Methods:
1. Prepare 1-2% w/v polymer solution in deionized water
2. In separate vessel, prepare 2-5% w/v NaIO4 solution in deionized water for
desired degree of oxidation
a. Theoretical DOO equivalent to Alginate:NaIO4 ratio
e.g. 10 DOO 1 g Alginate:0.1g NaIO4
3. Mix NaIO4 solution into alginate solution and allow to stir for 24 hrs at room
temperature in dark space
4. Dialyze against deionized water for 3 days
5. Freeze at -80°C and lyophilize
Note: Oxidation reaction can be stopped by addition of molar equivalent of ethylene
glycol to NaIO4
Reference:
Bouhadir, Kamal H., et al. "Degradation of partially oxidized alginate and its potential
application for tissue engineering." Biotechnology progress 17.5 (2001): 945-950.
Jeon, Oju, et al. "The effect of oxidation on the degradation of photocrosslinkable
alginate hydrogels." Biomaterials 33.13 (2012): 3503-3514.
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A.2 Burst Pressure Testing- Liquid Application
Goal: To quantify the burst pressure of a liquid hydrogel sealant on a collagen substrate
utilizing a custom fabricated burst pressure device and to perform failure analysis.
Materials:
 Hydrogel Precursor Solution and crosslinking system
 Syringe Pump (Harvard Apparaus PHD 200 Infusion)
 60 cc syringe (ExelInt, 26.7mm diameter)
 Burst Pressure Device- BPD (custom fabricated)
 Pressure Transducer (Omega PX406030AUSBH)
 Computer or Laptop
 Digital Microscope (DinoLite Pro AM413TA)
 Collagen Substrate (Collagen Middles Natural Protein, The Sausage Maker Inc)
 3mm biopsy punch
 2x3” glass slide
 Teflon Mold (2x3” with central 15mm diameter hole)
 Project clips
 Deionized water
Methods:
1) Prepare hydrogel precursor solution to desired concentration
2) Set up BPD.
a. Program Harvard Pump to prescribed values:
i. Syringe: 60cc, 26.7mm diameter
ii. Infusion Rate: 75ml/hr
iii. Mode: Volume Infusion
b. Place syringe on pump
c. Connect BPD to infusion pump via the luer-lock connector
i. Ensure an airtight seal. Parafilm can be wrapped around
connection to help form seal
d. Connect pressure transducer to BPD via NPT port
i. Ensure airtight seal. Teflon tape can be used in threading to help
form seal
e. Connect pressure transducer to laptop and open up data acquisition
software
i. Sampling rate can be adjusted to your desire, but 10Hz seems
suitable
ii. Adjust units accordingly. inH2O is useful for surgical sealant
applications as there is no cmH2O setting
3) Prepare collagen substrates
a. Cut collagen to form 3cm
squares
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b. Just prior to testing, rehydrate in deionized water for 5 minutes
4) Ensure the system is airtight and the collagen substrate is intact by testing
unpunctured substrate in BPD
a. Place collagen over hole in lower half of BPD
b. Place o-ring over collagen substrate
c. Place top half of BPD over substrate and O-ring
d. Connect two halves with two hand screws
e. Begin data acquisition software and engage syringe pump
f. After confirming pressure is building in system (via acquisition software),
disengage syringe pump and data acquisition and remove substrate from
BPD
5) Punch 3mm hole in center of collagen substrate
a. Confirm through thickness defect via testing on BPD or visual inspection
6) Clamp substrate between glass slide and Teflon mold such that puncture defect is
centered in the mold
7) Pour 0.5mL of hydrogel precursor solution into Teflon mold and crosslink in
place
a. Previous studies should be performed to determine necessary form and
duration of crosslinking
8) Unclamp mold and carefully remove Teflon top to minimize stress to sealant
9) Slide collagen substrate from glass slide to BPD to minimize stress to the sealant
10) Fix substrate into BDP so that puncture and sealant are centered
11) Place digital microscope over BPD and connect to computer
12) Begin video and data acquisition and engage pump
a. Allow pressure to build in device until failure (sealant is broken and
unable to withstand pressure)
13) Disengage syringe pump and data/video acquisition
a. Save data file as excel to recreate pressure curves
b. Video can be viewed to determine mode of failure
i. Delamination- sealant separates from substrate with no visible
damage
ii. Material Failure- patch fails directly above puncture but remains
adhered
14) Remove sample from BPD for examination and disposal
Note: This test can be performed on laboratory benchtop at room temperature or can be
relocated into an environmental incubator for testing in a humid environment at 37
celsius.
Reference:
ASTM F2392-04(2015), Standard Test Method for Burst Strength of Surgical Sealants,
ASTM International, West Conshohocken, PA, 2015, www.astm.org
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A.3 Burst Pressure Testing- Dry State Application
Goals: To quantify the burst pressure of a dry-state hydrogel sealant on a collagen
substrate utilizing a custom fabricated burst pressure device and to perform failure
analysis.
Materials:
 Hydrogel Precursor Patch and crosslinking system
 Syringe Pump (Harvard Apparaus PHD 200 Infusion)
 60 cc syringe (ExelInt, 26.7mm diameter)
 Burst Pressure Device- BPD (custom fabricated)
 Pressure Transducer (Omega PX406030AUSBH)
 Computer or Laptop
 Digital Microscope (DinoLite Pro AM413TA)
 Collagen Substrate (Collagen Middles Natural Protein, The Sausage Maker Inc)
 8mm Biopsy Punch
 1.5mm Biopsy Punch
 2x3” Glass Slide
 Teflon Mold (2x3” with central 15mm diameter hole)
 Mist Bottle
 Eye Dropper
 Deionized Water
Methods:
1. Punch prepared hydrogel precursor patch using 8mm biopsy punch
2. Set up BPD.
a. Program Harvard Pump to prescribed values:
i. Syringe: 60cc, 26.7mm diameter
ii. Infusion Rate: 75ml/hr
iii. Mode: Volume Infusion
b. Place syringe on pump
c. Connect BPD to infusion pump via the luer-lock connector
i. Ensure an airtight seal. Parafilm can be wrapped around
connection to help form seal
d. Connect pressure transducer to BPD via NPT port
i. Ensure airtight seal. Teflon tape can be used in threading to help
form seal
e. Connect pressure transducer to laptop and open up data acquisition
software
i. Sampling rate can be adjusted to your desire, but 10Hz seems
suitable
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ii. Adjust units accordingly. inH2O is useful for surgical sealant
applications as there is no cmH2O setting
3. Prepare collagen substrates
a. Cut collagen to form 3cm squares
b. Just prior to testing, rehydrate in deionized water for 5 minutes
4. Ensure the system is airtight and the collagen substrate is intact by testing
unpunctured substrate in BPD
a. Place collagen over hole in lower half of BPD
b. Place o-ring over collagen substrate
c. Place top half of BPD over substrate and O-ring
d. Connect two halves with two hand screws
e. Begin data acquisition software and engage syringe pump
f. After confirming pressure is building in system (via acquisition software),
disengage syringe pump and data acquisition and remove substrate from
BPD
5. Punch 1.5mm hole in center of collagen substrate
a. Confirm through thickness defect via testing on BPD or visual inspection
6. Lightly wet (mist bottle) collagen surface and place on glass slide
7. Apply 2 patches over defect and rehydrate with deionized water using eye dropper
a. Lightly apply pressure to patch to ensure solid contact with substrate
without damaging patch, which can be brittle and subject to cracking
b. Do not supersaturate hydrogel to avoid dissolution/dissolving
c. 1-2 drops of water per patch seems to suffice, but this amount should be
adjusted for patch thickness, composition, etc.
8. Cover remainder of substrate with Teflon mold to help prevent dehydration of
substrate during crosslinking
9. Crosslink patch in place
a. Previous studies should be performed to determine necessary form and
duration of crosslinking
b. Remove Teflon mold after crosslinking
10. Slide collagen substrate from glass slide to BPD to minimize stress to the sealant
11. Fix substrate into BDP so that puncture and sealant are centered
12. Place digital microscope over BPD and connect to computer
13. Begin video and data acquisition and engage pump
a. Allow pressure to build in device until failure (sealant is broken and
unable to withstand pressure)
14. Disengage syringe pump and data/video acquisition
a. Save data file as excel to recreate pressure curves
b. Video can be viewed to determine mode of failure
i. Delamination- sealant separates from substrate with no visible
damage
ii. Material Failure- patch fails directly above puncture but remains
adhered
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15. Remove sample from BPD for examination and disposal
Note: This test can be performed on laboratory benchtop at room temperature or can be
relocated into an environmental incubator for testing in a humid environment at 37
celsius.
Reference:
ASTM F2392-04(2015), Standard Test Method for Burst Strength of Surgical Sealants,
ASTM International, West Conshohocken, PA, 2015, www.astm.org
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